Address: No. 35, Simiao Road, Daxing Biomedical Industrial Base, Zhongguancun Science Park, Daxing District, Beijing
Copyright: Beijing Minhai Biological Technology Co., Ltd. Beijing ICP 10007676 Powered by www.300.cn Beijing Beijing Public Security No. 110115000037 Internet Drug Information Service Qualification Certificate (Beijing) Non-operating 20150173
Administrative Office: 010-59613600
Supplier consultation: 010-59613585
Medical support: 010-59613669
Minhai Company signed a contract with China Aviation Planning and Design Research Institute
On June 25, 2019, the signing ceremony of the design contract for the construction project of Minhai Biological New Vaccine International Industrial Base was held in the company's first conference room. The ceremony was presided over by Vice President Xiao Qiyou. The company's chairman Du Weimin, general manager Zheng Haifa, executive deputy general manager Liu Jiankai and other leaders, and deputy general manager Liu Zhongwen of the China Aviation Planning and Design Research Institute, dean Wei Shaohui and dean Zhang Wei of the Institute of Pharmaceutical Engineering Design and Research, attended the meeting.
At the ceremony, the company's chairman Du Weimin expressed his expectations for the design of the new vaccine base project, and emphasized the importance of the design work for the construction project. Mr. Du particularly pointed out: We must build excellent projects, pay attention to intelligence, and achieve long-term design concepts and high planning starting points, fully reflecting the requirements of scientific, standardization, intelligence, humanization, and gardening. After the project is completed, it will become a domestic and foreign biomedical research and development institution and a base for international talent research and development; establish the overall image of the biopharmaceutical industry as "international first-class, domestic leader".